메뉴 건너뛰기




Volumn 22, Issue SUPPL. 6, 2011, Pages

Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; AROMATASE INHIBITOR; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PLATINUM COMPLEX; TAMOXIFEN; TAXANE DERIVATIVE;

EID: 80052709218     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr374     Document Type: Article
Times cited : (155)

References (26)
  • 1
    • 84857100936 scopus 로고    scopus 로고
    • http://globocan.iarc.it.
  • 2
    • 78650685101 scopus 로고    scopus 로고
    • Should we screen for endometrial cancer?
    • Vergote I, Amant F, Timmerman D. Should we screen for endometrial cancer? Lancet Oncol 2011; 12: 4-5.
    • (2011) Lancet Oncol , vol.12 , pp. 4-5
    • Vergote, I.1    Amant, F.2    Timmerman, D.3
  • 4
    • 64049094855 scopus 로고    scopus 로고
    • FIGO Committee on Gynacologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
    • Pecorelli S. FIGO Committee on Gynacologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105: 103-104.
    • (2009) Int J Gynaecol Obstet , vol.105 , pp. 103-104
    • Pecorelli, S.1
  • 5
    • 0032860063 scopus 로고    scopus 로고
    • Radiologic staging in patients with endometrial cancer: a meta analysis
    • Kinkel K, Kaji Y, Yu KK et al. Radiologic staging in patients with endometrial cancer: a meta analysis. Radiology 1999; 212: 711-718.
    • (1999) Radiology , vol.212 , pp. 711-718
    • Kinkel, K.1    Kaji, Y.2    Yu, K.K.3
  • 6
    • 79751531175 scopus 로고    scopus 로고
    • Advances in magnetic resonance imaging of endometrial cancer
    • Sala E, Rockall A, Kubik-Huch RA. Advances in magnetic resonance imaging of endometrial cancer. Eur Radiol 2011; 21: 468-473.
    • (2011) Eur Radiol , vol.21 , pp. 468-473
    • Sala, E.1    Rockall, A.2    Kubik-Huch, R.A.3
  • 8
    • 6944253953 scopus 로고    scopus 로고
    • Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects
    • Clement PB, Young RH. Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2004; 11: 117-142.
    • (2004) Adv Anat Pathol , vol.11 , pp. 117-142
    • Clement, P.B.1    Young, R.H.2
  • 9
    • 0033919275 scopus 로고    scopus 로고
    • Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?
    • Mariani A, Webb MJ, Keeney GL et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000; 18: 1506-1519.
    • (2000) Am J Obstet Gynecol , vol.18 , pp. 1506-1519
    • Mariani, A.1    Webb, M.J.2    Keeney, G.L.3
  • 10
    • 69449098469 scopus 로고    scopus 로고
    • Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study
    • Sorbe B, Nordström B, Mäenpää J et al. Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study. Int J Gynecol Cancer 2009; 19: 873-878.
    • (2009) Int J Gynecol Cancer , vol.19 , pp. 873-878
    • Sorbe, B.1    Nordström, B.2    Mäenpää, J.3
  • 11
    • 2142640269 scopus 로고    scopus 로고
    • Outcome of highrisk Stage IC, Grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial
    • Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC et al. Outcome of highrisk Stage IC, Grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 2004; 22: 1234-1241.
    • (2004) J Clin Oncol , vol.22 , pp. 1234-1241
    • Creutzberg, C.L.1    van Putten, W.L.2    Warlam-Rodenhuis, C.C.3
  • 12
    • 1342321840 scopus 로고    scopus 로고
    • A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
    • Keys HM, Roberts JA, Brunetto VL et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92: 744-751.
    • (2004) Gynecol Oncol , vol.92 , pp. 744-751
    • Keys, H.M.1    Roberts, J.A.2    Brunetto, V.L.3
  • 13
    • 18144432776 scopus 로고    scopus 로고
    • Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
    • Creutzberg CL, van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000; 355: 1404-1411.
    • (2000) Lancet , vol.355 , pp. 1404-1411
    • Creutzberg, C.L.1    van Putten, W.L.2    Koper, P.C.3
  • 14
    • 58149186453 scopus 로고    scopus 로고
    • Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis
    • ASTEC/EN.5 Study Group
    • ASTEC/EN.5 Study Group. Blake P, Swart AM, Orton J et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009; 373: 137-146.
    • (2009) Lancet , vol.373 , pp. 137-146
    • Blake, P.1    Swart, A.M.2    Orton, J.3
  • 15
    • 77649130174 scopus 로고    scopus 로고
    • Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
    • Nout RA, Smit VT, Putter H et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 2010; 375: 816-823.
    • (2010) Lancet , vol.375 , pp. 816-823
    • Nout, R.A.1    Smit, V.T.2    Putter, H.3
  • 16
    • 33746911931 scopus 로고    scopus 로고
    • Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial
    • Maggi R, Lissoni A, Spina A et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 2006; 95: 266-271.
    • (2006) Br J Cancer , vol.95 , pp. 266-271
    • Maggi, R.1    Lissoni, A.2    Spina, A.3
  • 17
    • 37349026899 scopus 로고    scopus 로고
    • Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study
    • Susumu N, Sagae S, Udagawa Y et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008; 108: 226-233.
    • (2008) Gynecol Oncol , vol.108 , pp. 226-233
    • Susumu, N.1    Sagae, S.2    Udagawa, Y.3
  • 18
    • 33644836069 scopus 로고    scopus 로고
    • Randomized phase III trial of wholeabdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study
    • Randall ME, Filiaci VL, Muss H et al. Randomized phase III trial of wholeabdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2006; 24: 36-44.
    • (2006) J Clin Oncol , vol.24 , pp. 36-44
    • Randall, M.E.1    Filiaci, V.L.2    Muss, H.3
  • 19
    • 78650466579 scopus 로고    scopus 로고
    • Unresolved issue in the management of endometrial cancer
    • Holland C. Unresolved issue in the management of endometrial cancer. Expert Rev Anticancer Ther 2011; 11: 57-69.
    • (2011) Expert Rev Anticancer Ther , vol.11 , pp. 57-69
    • Holland, C.1
  • 20
    • 79960932312 scopus 로고    scopus 로고
    • Developments in the systemic treatment of endometrial cancer
    • Mountzios G, Pectasides D, Bournakis E et al. Developments in the systemic treatment of endometrial cancer. Crit Rev Oncol/Hematol 2010; 79(3): 278-292.
    • (2010) Crit Rev Oncol/Hematol , vol.79 , Issue.3 , pp. 278-292
    • Mountzios, G.1    Pectasides, D.2    Bournakis, E.3
  • 21
    • 47349110637 scopus 로고    scopus 로고
    • Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemoradiotherapy
    • Kuoppala T, Maenpaa J, Tomas E et al. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemoradiotherapy. Gynecol Oncol 2008; 110: 190-195.
    • (2008) Gynecol Oncol , vol.110 , pp. 190-195
    • Kuoppala, T.1    Maenpaa, J.2    Tomas, E.3
  • 22
    • 65649145790 scopus 로고    scopus 로고
    • Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma
    • Fader AN, Drake RD, O'Malley DM et al. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer 2009; 115: 2119-2127.
    • (2009) Cancer , vol.115 , pp. 2119-2127
    • Fader, A.N.1    Drake, R.D.2    O'Malley, D.M.3
  • 23
    • 5444224343 scopus 로고    scopus 로고
    • Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study
    • Thigpen JT, Brady MF, Homesley HD et al. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2004; 22: 3902-3908.
    • (2004) J Clin Oncol , vol.22 , pp. 3902-3908
    • Thigpen, J.T.1    Brady, M.F.2    Homesley, H.D.3
  • 24
    • 47649086616 scopus 로고    scopus 로고
    • Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up
    • Sorbe B, Andersson H, Boman K, Rosenberg P, Kalling M. Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up. Int J Gynecol Cancer 2008; 18: 803-808.
    • (2008) Int J Gynecol Cancer , vol.18 , pp. 803-808
    • Sorbe, B.1    Andersson, H.2    Boman, K.3    Rosenberg, P.4    Kalling, M.5
  • 25
    • 33847662544 scopus 로고    scopus 로고
    • Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration
    • Humber CE, Tierney JF, Symonds RP et al. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration. Ann Oncol 2007; 18: 409-420.
    • (2007) Ann Oncol , vol.18 , pp. 409-420
    • Humber, C.E.1    Tierney, J.F.2    Symonds, R.P.3
  • 26
    • 78049348519 scopus 로고    scopus 로고
    • Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' Staging System for uterine corpus cancer
    • Lewin SN, Herzog TJ, Barrena Medel LI et al. Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' Staging System for uterine corpus cancer. Obstet Gynecol 2010; 116: 1141-1149.
    • (2010) Obstet Gynecol , vol.116 , pp. 1141-1149
    • Lewin, S.N.1    Herzog, T.J.2    Barrena Medel, L.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.